Class information for:
Level 1: MRC TRIAL//ABORAT PREVENT TREATMENT CARDIOVASC DIS//CLIN EPIDEMIOL HLTH CARE PROGRAM MED

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23776 280 27.7 48%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
390 16316 MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 MRC TRIAL Author keyword 1 50% 1% 2
2 ABORAT PREVENT TREATMENT CARDIOVASC DIS Address 1 50% 0% 1
3 CLIN EPIDEMIOL HLTH CARE PROGRAM MED Address 1 50% 0% 1
4 GOVERNMENTAL GUIDELINES Author keyword 1 50% 0% 1
5 JNC V Author keyword 1 50% 0% 1
6 LEFT VENTRICULAR STRUCTURAL DISTURBANCES Author keyword 1 50% 0% 1
7 LOGISTIC RISK Author keyword 1 50% 0% 1
8 STUDIES OF LEFT VENTRICULAR DYSFUNCTION SOLVD Author keyword 1 50% 0% 1
9 CINDI Address 0 33% 0% 1
10 HASHARON MED Address 0 33% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 MRC TRIAL 1 50% 1% 2 Search MRC+TRIAL Search MRC+TRIAL
2 GOVERNMENTAL GUIDELINES 1 50% 0% 1 Search GOVERNMENTAL+GUIDELINES Search GOVERNMENTAL+GUIDELINES
3 JNC V 1 50% 0% 1 Search JNC+V Search JNC+V
4 LEFT VENTRICULAR STRUCTURAL DISTURBANCES 1 50% 0% 1 Search LEFT+VENTRICULAR+STRUCTURAL+DISTURBANCES Search LEFT+VENTRICULAR+STRUCTURAL+DISTURBANCES
5 LOGISTIC RISK 1 50% 0% 1 Search LOGISTIC+RISK Search LOGISTIC+RISK
6 STUDIES OF LEFT VENTRICULAR DYSFUNCTION SOLVD 1 50% 0% 1 Search STUDIES+OF+LEFT+VENTRICULAR+DYSFUNCTION+SOLVD Search STUDIES+OF+LEFT+VENTRICULAR+DYSFUNCTION+SOLVD
7 HYPERCHOLESTERAEMIA 0 33% 0% 1 Search HYPERCHOLESTERAEMIA Search HYPERCHOLESTERAEMIA
8 REHABILITATION COSTS 0 33% 0% 1 Search REHABILITATION+COSTS Search REHABILITATION+COSTS
9 DIURETICS BETA BLOCKERS 0 25% 0% 1 Search DIURETICS+BETA+BLOCKERS Search DIURETICS+BETA+BLOCKERS
10 POLICY PERSPECTIVE 0 25% 0% 1 Search POLICY+PERSPECTIVE Search POLICY+PERSPECTIVE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RANDOMIZED DRUG TRIALS 8 75% 2% 6
2 MODERATE HYPERTENSION 2 10% 8% 21
3 HYPERTENSION STOP HYPERTENSION 1 25% 1% 3
4 CANADIANS 55 1 50% 0% 1
5 LLA 1 50% 0% 1
6 UTILITY LOSS 1 50% 0% 1
7 MYOCARDIAL COLLAGEN MATRIX 1 29% 1% 2
8 TREATING HYPERTENSION 1 10% 2% 5
9 HYPERTENSIVE VETERANS 0 33% 0% 1
10 BRITISH FAMILY HEART 0 14% 1% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Pharmacoeconomics of hypertension management - The place of combination therapy 2001 18 64 38%
Pharmacoeconomic considerations in the management of hypertension 2000 24 36 31%
Adverse experience reporting for OTC medicines: Scientific/regulatory framework and review of a hypothetical case study 2004 1 4 25%
Aspects of pharmacoeconomical of reduction of left ventricular hypertrophy in hypertensive patients: How we can use the results of clinical trials 2004 0 8 38%
Hypertension-related morbidity and mortality in the southeastern United States 1997 95 109 8%
COST-EFFECTIVENESS ANALYSIS OF HYPERTENSION TREATMENT - A REVIEW OF METHODOLOGICAL ISSUES 1991 23 29 31%
Radiology 1996 43 64 8%
Cost effectiveness of coronary heart disease prevention strategies in adults 1998 16 54 9%
Hypertension: a policy perspective, 1976-2008 2009 4 16 6%
PRESSURE TO TREAT AND PRESSURE TO COST - A REVIEW OF COST-EFFECTIVENESS ANALYSIS 1991 20 17 18%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ABORAT PREVENT TREATMENT CARDIOVASC DIS 1 50% 0.4% 1
2 CLIN EPIDEMIOL HLTH CARE PROGRAM MED 1 50% 0.4% 1
3 CINDI 0 33% 0.4% 1
4 HASHARON MED 0 33% 0.4% 1
5 MARY IMOGENE BASSETT HOSP 0 33% 0.4% 1
6 AYATOLLAH ROUHANI HOSP 0 25% 0.4% 1
7 MINIST HLTH SERV 0 25% 0.4% 1
8 SOCIAL DETERMINANTS HLTH SDH 0 25% 0.4% 1
9 EDUC SCI AFFAIRS 0 17% 0.4% 1
10 HLTH ECON QUAL LIFE 0 17% 0.4% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000176875 MINICHAL//ANTIHYPERTENSIVE DRUG CLASSES//ANTIHYPERTENSIVE REGIMENS
2 0.0000173029 IST MED INTERNA VASCOLARE//AALENS MODEL//ADJUSTED SURVIVAL
3 0.0000152965 AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY
4 0.0000145384 APPOINTMENT NON ATTENDANCE//EBELTOFT HLTH PROMOT STUDY//MULTIPHASIC SCREENING
5 0.0000105268 INTEGRATED CARDIOVASC CLIN NETWORK SA//PREVENTAT HLTH//ANGIOTENSIN CONVERTING ENZYME INHIBITOR THERAPY
6 0.0000095660 FRICTION COSTS//PRODUCTIVITY COSTS//COST OF SMOKING
7 0.0000094482 MULTIPLE INDUSTRIES//RETURN ON INNOVATION//VALUE TRANSFERENCE
8 0.0000091560 URBAN POLICY ADM//ASSESSMENT OF HEALTHCARE NEEDS//HEALTHCARE ASSISTANCE
9 0.0000074329 MEDICATION ADHERENCE//PATIENT COMPLIANCE//MORISKY SCALE
10 0.0000069750 PREHYPERTENSION//HYPERTENSION PREVALENCE//HIGH NORMAL BLOOD PRESSURE